Thermo Fisher Scientific's Stock Performance: A Comparative Analysis with the Dow Jones Industrial Average

Thermo Fisher Scientific, a $186.6 billion life sciences company, has seen its stock retreat 21.5% from its 52-week high but has surged 22% over the past three months, outpacing the Dow Jones Industrial Average. Despite this, TMO stock has dropped 19.6% over the past 52 weeks, trailing the Dow Jones Industrial Average’s 10.8% increase. TMO has been trading above its 50-day and 200-day moving averages since early July and mid-August, indicating a recent uptrend.